FPH Building Programme Underway in New Zealand

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

FISHER & PAYKEL HEALTHCARE BUILDING PROGRAMME UNDERWAY IN NEW ZEALAND
Auckland, New Zealand, 18 December 2017 - Fisher & Paykel Healthcare announced today that it
has signed a building construction contract with Leighs Construction for the fourth building on its
Auckland campus.

The new building will have a total gross floor area of 35,700m
2
and consist of a mix of R&D, pilot
manufacturing and warehousing areas. Groundworks have been substantially completed, and
construction will commence in late January 2018, with an expected operational date of 2020.

The new building will bring Fisher & Paykel Healthcare’s Auckland campus to a total of four
buildings. The 42 hectare grounds currently host 2,300 employees, more than half of the
company’s total global people of 4,100. The new building will accommodate expected growth until
around 2023.

“The new building will be an exciting addition to our campus,” said Jonti Rhodes, General Manager
Supply Chain, Environment & Facilities. “The blend of R&D, manufacturing and warehousing that
we have in our existing buildings gives us a very open working environment and helps us work
collaboratively across functional groups. It’s a unique, modern way of working that we are looking
forward to developing further in the new building.”

The company has also commenced a building programme in Tijuana, Mexico, where construction
of a second manufacturing facility is underway with an anticipated completion date of late 2018.
The company has more than 950 employees in Tijuana, where it has been manufacturing in a
leased facility since 2010.

The total cost of the building projects in New Zealand and Mexico is expected to be approximately
NZ$200M. The new buildings will assist the company to accommodate the strong revenue and
people growth anticipated over the coming decade.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep
apnea. The company’s products are sold in over 120 countries worldwide. For more information
about the company, visit our website www.fphcare.com
.

Ends

Contact:
Investors:
Marcus Driller
General Manager Corporate
marcus.driller@fphcare.co.nz
+64 (0) 27 578 9663
Media:
Rachel Reynolds
Senior Communications Manager
rachel.reynolds@fphcare.co.nz
+64 (0) 21 713 911